Posts Tagged ‘hipertensió pulmonar’

Wednesday September 16th, 2015

An initial combined treatment for pulmonary arterial hypertension provides better long-term results

A study published in the New England Journal of Medicine (NEJM) shows that the combination of two drugs (ambrisentan and tadalafil) is more effective than the use of one of these agents to treat pulmonary arterial hypertension. The combination therapy improves very significantly the outcome of patients with this disease and reduces by 50% the risk of clinical failure. Dr. Joan Albert Barberà, pulmonologist at Hospital Clínic and head of the IDIBAPS team Physiopathological mechanisms of respiratory illnesses is one of the authors of this study and coordinator of the trial in Spain.

Read the rest of this entry »

Comments Closed
Thursday March 05th, 2015

Dr. Barberà, coordinator of the new CIBERES research program in pulmonary hypertension

Dr. Joan Albert Barberà coordinates the Corporate Research Program (CRP) on pulmonary hypertension that has launched the Networked Biomedical Research Center for Respiratory Diseases (CIBERES). The program’s main goal is to identify markers that will help in the diagnosis and to find new therapeutic targets for this disease. Dr. Barbera is pneumologist at Hospital Clínic, leader of the IDIBAPS team Pathophysiological Mechanisms of Respiratory Ilnesses and researcher at CIBERES.

Read the rest of this entry »

Comments Closed